» Authors » Maryline Allegra

Maryline Allegra

Explore the profile of Maryline Allegra including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 34
Citations 707
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Goffinet S, Bontoux C, Heeke S, Pezzuto F, Ilie M, Long-Mira E, et al.
Virchows Arch . 2024 Dec; PMID: 39741211
EGFR status assessment is mandatory for adjuvant decision-making of resected stage IB-IIIA non-squamous non-small cell lung cancer (NS-NSCLC). It is questionable whether single-gene RT-PCR versus next-generation sequencing (NGS) should be...
2.
Bontoux C, Lespinet-Fabre V, Bordone O, Tanga V, Allegra M, Salah M, et al.
J Vis Exp . 2023 Sep; (199). PMID: 37747233
The number of molecular alterations to be tested for targeted therapy of non-squamous non-small cell lung cancer (NS-NSCLC) patients has significantly increased these last few years. The detection of molecular...
3.
Martel A, Gastaud L, Bonnetaud C, Nahon-Esteve S, Washetine K, Bordone O, et al.
Cancers (Basel) . 2023 May; 15(8). PMID: 37190299
Ophthalmic malignancies include various rare neoplasms involving the conjunctiva, the uvea, or the periocular area. These tumors are characterized by their scarcity as well as their histological, and sometimes genetic,...
4.
Ilie M, Benzaquen J, Hofman V, Long-Mira E, Lassalle S, Boutros J, et al.
Int J Mol Sci . 2023 Feb; 24(4). PMID: 36834888
As new SARS-CoV-2 variants emerge, there is an urgent need to increase the efficiency and availability of viral genome sequencing, notably to detect the lineage in samples with a low...
5.
Hofman V, Heeke S, Bontoux C, Chalabreysse L, Barritault M, Bringuier P, et al.
JTO Clin Res Rep . 2023 Jan; 4(2):100457. PMID: 36718140
Introduction: Gene fusion testing of , , , , and exon 14 skipping mutations is guideline recommended in nonsquamous NSCLC (NS-NSCLC). Nevertheless, assessment is often hindered by the limited availability...
6.
Khatir W, Humbert O, Benzaquen J, Bontoux C, Neels J, Berland L, et al.
Clin Transl Med . 2022 Aug; 12(8):e1018. PMID: 35994416
No abstract available.
7.
Martinuzzi E, Benzaquen J, Guerin O, Leroy S, Simon T, Ilie M, et al.
Clin Infect Dis . 2022 May; 75(12):2053-2059. PMID: 35579991
Background: Mucosal antibodies can prevent virus entry and replication in mucosal epithelial cells and therefore virus shedding. Parenteral booster injection of a vaccine against a mucosal pathogen promotes stronger mucosal...
8.
Ilie M, Hofman V, Bontoux C, Heeke S, Lespinet-Fabre V, Bordone O, et al.
Cancers (Basel) . 2022 May; 14(9). PMID: 35565387
The number of genomic alterations required for targeted therapy of non-squamous non-small cell lung cancer (NS-NSCLC) patients has increased and become more complex these last few years. These molecular abnormalities...
9.
Hofman P, Bordone O, Chamorey E, Benzaquen J, Schiappa R, Lespinet-Fabre V, et al.
Front Med (Lausanne) . 2022 Jan; 8:730577. PMID: 35087842
Aside from the reverse transcription-PCR tests for the diagnosis of the COVID-19 in routine clinical care and population-scale screening, there is an urgent need to increase the number and the...
10.
Boutros J, Benzaquen J, Marquette C, Ilie M, Labaky M, Benchetrit D, et al.
ERJ Open Res . 2021 Dec; 7(4). PMID: 34877351
Background: The current diagnostic standard for coronavirus disease 2019 (COVID-19) is reverse transcriptase-polymerase chain reaction (RT-PCR) testing with nasopharyngeal (NP) swabs. The invasiveness and need for trained personnel make the...